Quick Answer
Immunocore Holdings plc reported Stockholders Equity of $381.03 million for fiscal year 2025.
Immunocore Holdings plc Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $381.03M | +5.6% |
| 2024 | $360.72M | -2.2% |
| 2023 | $368.84M | +8.8% |
| 2022 | $338.90M | +45.0% |
| 2021 | $233.71M | +203.9% |
| 2020 | $76.91M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $396.56M | +5.0% | +2.1% |
| June 30, 2025 | $388.48M | +8.2% | +2.6% |
| March 31, 2025 | $378.48M | +5.3% | +4.9% |
| December 31, 2024 | $360.72M | -2.2% | -4.5% |
| September 30, 2024 | $377.83M | +6.1% | +5.2% |
| June 30, 2024 | $359.14M | +2.2% | -0.1% |
| March 31, 2024 | $359.53M | +5.3% | -2.5% |
| December 31, 2023 | $368.84M | +8.8% | +3.6% |
- Immunocore Holdings plc showed an increase of +5.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, Immunocore Holdings plc’s stockholders equity has grown by 395.4% (from $76.91 million to $381.03 million).
- The most recent figure is from Immunocore Holdings plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: